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Introduction and aim: The identification of right ventricular abnormalities in patients with arrhythmogenic right
ventricular cardiomyopathy (ARVC) in early stages is still difficult. The aim of this study was to investigate if
longitudinal strain based on speckle tracking can detect subtle right (RV) or left ventricular (LV) dysfunction as an
early sign of ARVC.
Methods and results: Seventeen male patients, fulfilling Task force criteria for ARVC, 49 (32–70) years old, nineteen
male first degree relatives 29 (19–73) y.o. and twenty-two healthy male volunteers 36 (24–66) y.o participated in the
study. Twelve-lead and signal-averaged electrocardiograms were recorded. All subjects underwent
echocardiography. LV and RV diameters, peak systolic velocity from tissue Doppler and longitudinal strain based on
speckle tracking were measured from the basal and mid segments in both ventricles. RV longitudinal strain
measurement was successful in first degree relatives and controls (95 resp. 86%) but less feasible in patients (59%).
Results were not systematically different between first degree relatives and controls. Using discriminant analysis, we
then developed an index based on echocardiographic parameters. All normal controls had an index < l while
patients with abnormal ventricles had an index between 1–4. Some of the first degree relatives deviated from the
normal pattern.
Conclusion: Longitudinal strain of LV and RV segments was significantly lower in patients than in relatives and
controls. An index was developed incorporating dimensional and functional echocardiographic parameters. In
combination with genetic testing this index might help to detect early phenotype expression in mutation carriers.
Keywords: Arrhythmogenic right ventricular cardiomyopathy, Right ventricle, Strain, Echocardiography, Right
ventricular functionIntroduction
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
is characterized by fibro-fatty substitution of the myocar-
dium in the right (RV) and, not infrequently, in the left
ventricle (LV). The loss of normal myocardium and the* Correspondence: meriam.astrom.aneq@lio.se
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reproduction in any medium, provided the ordevelopment of scar is associated with electrical instability
manifested as ventricular arrhythmia and potential sudden
death [1]. A less common manifestation is right ventricular
dysfunction causing heart failure and thromboembolism.
ARVC is typically transmitted as an autosomal dominant
trait with variable expressivity and penetrance [2]. Current
guidelines recommend that all first degree relatives of a
patient with ARVC undergo screening as sudden cardiac
death may be the initial manifestation of the disease. Dur-
ing the past decade, several genes and loci have been iden-
tified as responsible for ARVC [3]. The availability of
molecular genetic testing allows the identification of gene-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ledge about long-term outcome in genetically-affected
relatives, lifelong follow-up of these relatives is required
for early detection of signs of disease.
In addition to resting ECG, imaging of the RV by
two-dimensional echocardiography (2D) is the most im-
portant screening method. The identification of RV ab-
normalities using echocardiography is still a major
challenge because of the geometric shape of the RV and
the patchy involvement of the right ventricular wall
with subtle abnormalities at an early stage.
Recently, a 2D strain echocardiographic method [4-7]
has been introduced that measures myocardial deform-
ation by tracking localized acoustic markers frame by
frame (speckle tracking). This method has been used for
noninvasive assessment of regional myocardial strain in
the left [8-10] and right [11] ventricle, avoiding the an-
gular sensitivity of tissue Doppler echocardiography.
We hypothesized that right and left ventricular longi-
tudinal strain derived from speckle tracking could be
used as a sensitive tool for the detection of subclinical
ventricular dysfunction in first degree relatives of ARVC
patients.
The aim of this study was (1) to test the feasibility of
the method when applied on the RV in patients with
ARVC and their relatives, (2) to investigate whether first
degree relatives of ARVC patients have reduced longitu-
dinal strain by speckle tracking as an early sign of myo-
cardial dysfunction, compared to controls.
Material and methods
Study population
ARVC affects females less often than males [12]. In this
study we have focused upon male patients as well as their
male relatives and matched controls, to avoid potential
gender differences in myocardial functional parameters.
ARVC patients
Patients were referred from hospitals and primary care
centres in the southeast of Sweden for investigation and
follow-up of ARVC. Since 1994, 19 males have been
diagnosed with ARVC based on fulfilment of the Task
Force Criteria of the European Society of Cardiology
[13]. Two patients underwent heart transplantation be-
fore start of this study and were excluded. The
remaining 17 males were included in the study.
First degree relatives
All first degree male relatives of ARVC patients (chil-
dren, parents or siblings), 18 years or older, underwent
screening at our tertiary care referral centre. One of
them fulfilled criteria for ARVC at the screening visit
and was excluded, resulting in 19 relatives, not fulfilling
original Task Force criteria, in the study. Kinship hasbeen established from voluntary information from the
patients and was not checked with DNA testing.
Controls
Twenty-four healthy male volunteers were recruited. All
were asymptomatic and lacked family history of prema-
ture cardiovascular disease. No one was on cardiac
medication. The selection of controls was based on
matching age to that of the group of relatives, aiming at
an age difference < 5 years. Two intended controls were
excluded, one due to left bundle branch block (LBBB)
on ECG and one due to an abnormal ST-reaction on ex-
ercise testing leaving 22 for inclusion. Ethical approval
for the study was obtained from the Regional Ethical Re-
view Board in Linköping.
Procedure
The three separate groups - ARVC patients, their first
degree relatives and healthy controls - were evaluated by
medical history, blood pressure measurement and
twelve-lead electrocardiography (ECG). A bicycle exer-
cise test was performed for ruling out significant heart
disease. A signal-averaged ECG (SAECG) using 40 Hz
high-pass filter was recorded in patients and relatives
but not in the healthy volunteers. Positive late potentials
were diagnosed when at least two of the three criteria
proposed by Breithardt [14] were present.
Echocardiography was performed with the subjects at
rest in the left lateral decubitus position using Vivid 5 or
Vivid 7 echocardiographic scanners (GE Medical Sys-
tems, Horten, Norway). All images were stored digitally
and analyzed on the Echo Pac work station (GE Medical
Systems, EchopacPC, version 6.0.1).
A comprehensive 2D, colour, pulsed, and continuous-
wave Doppler examination was performed following the
recommendations of the American Society of Echocardi-
ography for transthoracic studies. Parasternal long-axis
views were used to derive M-mode measurement of left
ventricular (LV) end-diastolic dimension, and to deter-
mine aortic valve opening (AVO) and closure (AVC). All
timing information was in relation to the ECG. The right
ventricular (RV) inflow and outflow diameter was mea-
sured from the 2D images and indexed to body surface
area (RVIT/BSA and RVOT/BSA). Tricuspid annular
motion (TAPSE) was recorded at the right ventricular
free wall using cross sectional guided M-mode.
Colour tissue Doppler myocardial imaging of the LV
and RV was performed in the apical four-chamber view,
at high frame rate (>100 frames/s). Three consecutive
beats were recorded for off line analysis. Mitral and tri-
cuspid annular systolic velocities (Sw) as well as early
(Ew) and late diastolic velocities (Aw) were measured in
the lateral LV wall, septum and RV free wall with a re-
gion of interest (ROI) size of 3 mm.
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The two dimensional four chamber view was recorded
with a frame rate ranging between 40 and 70 frames/s.
The endocardial border was traced offline and the ROI
was manually adjusted to include the myocardial wall.
The software then automatically tracked wall motion
over the entire cardiac cycle and measurements were
accepted from segments of good tracking quality. The
observer was allowed to manually readjust some but not
all aspects of the tracking procedure. Systolic longitu-
dinal strain was assessed from the basal and mid seg-
ments in the lateral LV wall, septum and RV free wall,
Figure 1.
All strain measurements were repeated by the same
observer who was blinded to the initial values, at least
5 weeks after the first analysis, in a random sample of 12
echocardiographic studies (4 from each patient group).
To define interobserver variability, measurements in the
same random sample were assessed by a second inde-
pendent observer blinded to the results obtained by the
previous investigator. The investigator was blinded for
the analysis of echocardiographic data.
Data analysis and statistics
Results were expressed as median (range) for patient
details (Table 1) and mean and standard deviation for
echocardiographic variables, which were reasonably well
normally distributed.Figure 1 Determination of longitudinal strain in an apical four chamb
shows average segmental strain graphically displayed (upper) and an M-mInter- and intraobserver variability was expressed as
standard error of a single determination (Smethod) using
the formula first proposed by Dahlberg[15]. Smethod was
also expressed as % over all means. The coefficient of
variation (COV) is the standard deviation of the differ-
ences divided by the mean of the measurements and
expressed as a percentage.
Results
Clinical characteristics and ECG
Two of the 19 relatives (11%) had a history of occasional
palpitations but ventricular ectopy was not seen on the
resting ECG or at the exercise test.
The resting ECG did not demonstrate inverted T-waves
beyond precordial lead V1 in the relatives or in the control
group while abnormal, negative T-waves in right sided
precordial leads were seen in 13 patients with ARVC
(76%). In addition, two had right bundle branch block.
One person among the relatives, 3 among controls and 4
patients had incomplete RBBB. Late potentials (defined as
fulfilment of at least 2 of 3 criteria) were found in 9/14
(64%) of ARVC patients, but in 2 patients SAECG was not
recorded because of frequents arrhythmias and in one
case due to ongoing cardiac pacing. Among the first de-
gree relatives 3/19 (16%) had positive late potentials. No
one in the control group had positive late potentials.
Three (16%) of the first degree relatives were on beta-
blockers for mild arterial hypertension. In the ARVCer view. Left side: Colour display of peak systolic strain. The right side
ode representation of peak systolic strain (lower).
Table 1 Subject clinical details
ARVC (n = 17) Relatives (n = 19) Controls (n = 22) P-value P-value*
Median (range) Median (range) Median (range)
Age (years) 49 (32–70) 29 (19–73) 36 (24–66) 0.024 0.445
Heart rate (bpm) 58 (45–90) 62 (49–88) 68 (45–94) 0.178 0.121
BMI (kg/m2) 25.3 (20.2–32.2) 24.3 (20.5–42.6) 22.5 (18.8–28.1) 0.177 0.371
BSA (m2) 1.96 (1.65–2.39) 2.00 (1.73–2.64) 1.97 (1.71–2.25) 0.898 0.990
SBP (mmHg) 130 (100–170) 130 (110–155) 120 (105–140) 0.078 0.045
DBP (mmHg) 80 (60–95) 80 (60–90) 70 (60–90) 0.002 0.018
Arrhythmia-related symptoms 13 (76%) 2 (11%) 0 - -
Differences between groups analyzed using non-parametric ANOVA.
* Controls vs. relatives using Mann–Whitney U-test.
BMI is body mass index, BSA is body surface area, SBP and DBP are systolic respective diastolic blood pressure.
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arrhythmia, arterial hypertension or heart failure. Nine
patients (53%) had an implantable cardioverter defibrilla-
tor (ICD).
Echocardiography
Longitudinal strain measurement using speckle tracking
was successful in the left ventricular walls in 15 of 17
(88%) patients, 18 of 19 (95%) first degree relatives and
19 of 22 (86%) controls. For the right ventricular free
wall, 2D-strain measurement was feasible in both seg-
ments in 10 of 17 (59%) patients. However, two patients
had unreliable values in the mid RV). In first degree
relatives and controls, 2D-strain in the RV free wall wasTable 2 Echocardiographic findings in the three groups
ARVC (n= 17) Relativ
Mean (SD) Me
LV diameter (mm) 52.6 (6.4) 5
RVOT/BSA (cm/m2) 2.0 (0.4)
RVIT/BSA (cm/m2) 2.3 (0.5)
LVOT VTI (cm) 18.8 (5.5) 2
TAPSE (mm) 19.1 (5.0) 2
Sw lat. LV (cm/s) 6.6 (2.3)
Sw Sept. (cm/s) 5.7 (1.6)
Sw RV free wall (cm/s) 8.2 (2.5) 1
E/A LV 1.3 (0.5)
E/E’ LV 8.8 (3.2)
2D strain LV base (%) −17.3 (4.4) −1
2D strain LV mid (%) −15.3 (4.9) −1
2D strain sept base (%) −14.9 (3.6) −1
2D strain sept mid (%) −15.2 (5.6) −1
2D strain RV base (%) −16.0 (6.8) −2
2D strain RV mid (%) −18.9 (5.9) −2
* Controls vs. relatives using Student’s t-test.
Right ventricular outflow and inflow diameter related to BSA(RVOT/BSA resp.RVIT/B
plane systolic excursion (TAPSE), systolic velocity at AV-plane in lateral LV (SwLV), seobtained in 18 of 19 (95%) and 19 of 22 (86%), respect-
ively. Missing data was mostly due to signal dropout,
artifact or a very thin wall in the region of interest mak-
ing wall motion tracking unreliable.
The left ventricular diameter was significantly larger in
the relatives compared to the controls and the patients.
A significantly lower myocardial velocity was detected in
the left lateral wall compared to the septum, lowest in
the patients and highest in the controls. Except for a
lower longitudinal strain value in the basal septum in
relatives compared to controls, there were no significant
differences between the first degree relatives and con-
trols for the remaining parameters (Table 2 and
Figure 2).es (n = 19) Controls (n = 22) P-value*
an (SD) Mean (SD)
4.6 (4.4) 51.3 (2.9) 0.009
1.6 (0.2) 1.6 (0.2) 0.981
1.9 (0.2) 1.8 (0.2) 0.674
1.3 (2.5) 20.9 (2.4) 0.555
5.3 (2.9) 25.3 (3.0) 0.963
7.3 (1.2) 8.5 (1.9) 0.018
6.6 (1.0) 7.1 (0.9) 0.115
1.2 (1.9) 11.6 (1.7) 0.545
1.8 (0.6) 1.7 (0.4) 0.600
6.4 (2.1) 6.1 (1.6) 0.608
9.6 (2.7) −20.2 (3.5) 0.518
8.3 (3.2) −18.3 (2.4) 0.968
5.8 (2.9) −17.8 (2.5) 0.025
8.5 (2.9) −18.2 (2.1) 0.636
6.8 (2.9) −28.5 (3.6) 0.121
7.3 (4.5) −27.2 (3.5) 0.945
SA), Left ventricular outflow velocity time integral (LVOT VTI), tricuspid annular
ptum (Sw sept) and RV wall (Sw RV).
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Figure 2 Longitudinal strain using speckle tracking in the base and mid lateral left ventricular (LV), septum (sept) and right ventricular
free (RV) wall in patients with ARVC, their first degree relatives and controls. Black dots represent subjects. Boxes, mean values and
standard deviation.
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Figure 3 The distribution of measurements from first degree
relatives in relation to ARVC patients and controls using a left
and a right ventricular index calculated by discriminant
analysis.
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strain 1.6 percentage points (PP) (COV= 8.2%), the same
in various locations of the heart. The inter-individual
error was, as expected, greater, 2.5 PP (COV=12.7%),
with 2D strain error in the mid level of the RV being sig-
nificantly greater expressed in absolute but not in rela-
tive terms (3.94 PP, COV= 15.7%), otherwise no
significant differences were found between different
parts of the heart.
Based on measurement results from the patient group
and the volunteers, a multivariate discriminant analysis
was performed to detect differences between ARVC-
patients and controls in order to investigate the relative
role of different parameters from the right and left ven-
tricle for the discrimination of the two groups. The di-
mensional and functional parameters used for the right
ventricle were RVOT/BSA, RVIT/BSA, TAPSE, Sw and
longitudinal strain based on speckle tracking of the basal
and mid RV free wall segments. For the left ventricle the
parameters were LV diameter, LVOT VTI, Sw from the
lateral and septal walls, strain based on speckle tracking
of the basal and mid segments of the septum and lateral
wall. Significant components were reassembled to create
separate indices for the right and left ventricles and
recalculated for each individual.
The following discriminant function was obtained
using parameters from the right ventricle:
Proposed index for the right ventricle
¼ lnðRVIT=BSAÞ  Sw RV free wall
 0:71þ2D strain RV base
 0:852 2D strain RV mid  0:418 Agecat
 1:276þ 12:
The different age categories (Agecat) were defined as
follows: 1 is ≤27, 2 is 28–38, 3 is 39–58 and 4 is
>58 years of age and ln is the natural logarithm.
The corresponding equation for the left ventricle was:
Proposed index for the left ventricle
¼ LV diameter per BSA  0:393  Sw lat LV
 0:494Sw sept  0:011þ2D strain sept base
 0:261  Agecat  0:028 3:
These indices were applied to the group of first degree
relatives.
Results of the ARVC discrimination index are depicted
in Figure 3. All individuals were also ranked according
to their index for the right ventricle in order to identify
relatives who had an echocardiographic pattern similar
to that of the patients.Discussion
New methods for the assessment of myocardial function
have broadened the utility of echocardiography in
detecting and understanding the effect of contraction
abnormalities of the heart, sometimes in subclinical
phases of disease [16-18].
In this investigation we have studied RV and LV func-
tion using the speckle tracking method.
Speckle tracking was feasible in regions of interest
from both ventricles in patients, relatives and controls.
However, longitudinal strain measurements in the right
ventricular free wall were more often unreliable in
patients (41%) than in relatives and controls. This can
be explained by the main pathologic feature of the dis-
ease, with myocardial degeneration causing thinning of
the right ventricular wall, prohibiting tracking with the
present version of the software. Using the same soft-
ware, Teske et al. showed a higher feasibility [19,20] of
speckle tracking measurements in their group of
ARVC patients compared to ours. This could partly be
explained by differences between groups in the severity
of disease.
The inter- and intraobserver variability of speckle
tracking measurements was low in both ventricles with
low bias and low limits of agreement. As expected the
interobserver variability was slightly higher than the
intraobserver variability and both measurements were
higher for the right ventricular free wall than for the
septum and left ventricular lateral wall.
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derived strain is reduced in the right as well as in the left
ventricular walls in patients, confirming the biventricular
involvement in ARVC [21-24], but there was no system-
atic difference in-between relatives and controls.
Echocardiographic findings can be discrete in the early
stages of the disease, complicating early diagnosis as
Corrado et al. have pointed out [25].
ARVC is a progressive disease that can have variable
phenotypic expression. Sometimes, malignant ventricu-
lar arrhythmia or sudden cardiac death are the initial
manifestations.
On the cellular level, it is a disease of the desmosome
which affects the cell-adhesion proteins leading to cardi-
omyocyte detachment and death. ARVC is an autosomal
dominant disease in at least 50% of cases [13,26]. The
recent development of genetic tests has given a new di-
mension to the understanding of the disease and enabled
the identification of genetically positive probands. How-
ever genetic screening is still a matter of research and
the variable penetrance of ARVC complicates the clinical
significance of a positive finding. During the past
20 years, task force criteria have been useful for diagno-
sis of ARVC in index patients. However such criteria
have demonstrated a low sensitivity in the early stages of
the disease. To increase the sensitivity in family screen-
ing of patients with proven ARVC, modifications to the
Task Force Criteria have recently been proposed [27].
Family screening relies on symptoms and findings in
ECG, signal average-ECG, echocardiography and MRI.
However echocardiographic abnormalities in the right
ventricular wall are still difficult to detect as they can be
localised to small areas. Furthermore, visual analysis of
RV function from two dimensional grey scale imaging is
subjective and can be unreliable for follow-up. New
echocardiographic techniques such as measuring the
amplitude of tricuspid annular motion (TAPSE) and
measurement of myocardial wall velocity using tissue
Doppler have improved the accuracy of RV wall motion
analysis [28-30]. In recent years assessment of RV myo-
cardial deformation [strain (S) and strain rate (SR) by
tissue Doppler has been used in different populations
[31]. However, the angle dependency of Doppler S and
SR is particularly relevant for the right ventricular free
wall and its triangular, oblique shape in the 4 -chamber
view. Speckle tracking echocardiography is less dependent
on the angle of insonation. Speckle tracking has been well
validated in vitro and in vivo. Clinical application of this
method to left ventricular function already exists [32-36].
The use of speckle tracking for the assessment of right
ventricular function is less investigated but studies are
slowly accumulating [37-39].
Using a combination of echocardiographic parameters
that were significant in discriminant analysis, we thereforedeveloped an index for the right and the left ventricle
based on dimensions and function. Values for these indi-
ces in excess of 1 suggest that such an individual expresses
features of disturbed ventricular function. While all
healthy control subjects had RV and LV indices lower than
1, some of the first- degree relatives deviated from this
normal pattern. It is noteworthy that the LV index was
frequently abnormal, supporting our previous finding that
LV involvement may be an earlier feature of the disease
than generally appreciated [21,22]. It should be kept in
mind that a substantial number of relatives are non-
carriers of the disease gene and their normal echocardio-
graphic findings tend to dilute the effect of reduced
measurements on group mean values. An interesting find-
ing in the discriminant analysis was the high impact of
myocardial velocity and longitudinal strain based on
speckle tracking determined in the right ventricular free
wall. Compared to these two measurements, TAPSE was
not an independent significant factor. This is in agreement
with previous findings that systolic velocity and strain are
more sensitive in detecting changes in right ventricular
function than TAPSE [40]. Our proposed index, combin-
ing different echocardiographic parameters may increase
the detection of subclinical changes in relatives.
We suggest that using left and right ventricular indices
may be useful, as an abnormal index may be an early
sign of the disease. In patients with an established diag-
nosis of ARVC, the index method may be used as an ob-
jective tool for following the progress of the disease.
Limitations
In this study we have focused upon male patients as well
as their male relatives and matched controls, to avoid
that potential gender differences in myocardial function
would influence the relationships studied by adding a
smaller number of females to the study group at this
stage.
Inclusion of larger number of patients and relatives
would strengthen the results, however expanding num-
bers is difficult due to the rarity of the disease. It is too
early to assess the discriminating power of the proposed
index based on this cohort of males, since the group is
rather small and needs external validation in independ-
ent cohorts. The index is intended to continue to be
tested as future first degree relatives are identified and
entered into the screening programme.
Conclusion
Measurement of longitudinal strain based on speckle
tracking was feasible for RV functional analysis in first de-
gree relatives and in the majority of index patients with
ARVC. Strain data of individual LV or RV segments were
significantly lower in patients than in controls but did not
differ between first degree relatives of ARVC patients and
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combination of LV and RV dimensional and functional
parameters derived from echocardiography that is pro-
posed for the detection of subclinical echocardiographic
abnormalities. In combination with genetic testing, this
index might help to find early phenotype expression in
mutation carriers relatives of ARVC patients, but needs
validation in external and preferably larger populations of
first degree relatives of ARVC patients.
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